Traphaco JSC - Asset Resilience Ratio
Traphaco JSC (TRA) has an Asset Resilience Ratio of 21.64% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check TRA capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how Traphaco JSC's Asset Resilience Ratio has changed over time. See net asset quality index of Traphaco JSC to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Traphaco JSC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see TRA market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₫0.00 | 0% |
| Short-term Investments | ₫521.51 Billion | 21.64% |
| Total Liquid Assets | ₫521.51 Billion | 21.64% |
Asset Resilience Insights
- Good Liquidity Position: Traphaco JSC maintains a healthy 21.64% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Traphaco JSC Industry Peers by Asset Resilience Ratio
Compare Traphaco JSC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
Drug Manufacturers - Specialty & Generic | 11.69% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131 |
Drug Manufacturers - Specialty & Generic | 1.37% |
|
Bausch Health Companies Inc
TO:BHC |
Drug Manufacturers - Specialty & Generic | 4.97% |
|
Dezhan HealthCare Co Ltd
SHE:000813 |
Drug Manufacturers - Specialty & Generic | 0.15% |
|
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Hainan Haiyao Co Ltd
SHE:000566 |
Drug Manufacturers - Specialty & Generic | 3.27% |
|
Shanxi Zhendong Pharmaceutical
SHE:300158 |
Drug Manufacturers - Specialty & Generic | 10.74% |
Annual Asset Resilience Ratio for Traphaco JSC (2019–2025)
The table below shows the annual Asset Resilience Ratio data for Traphaco JSC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 22.80% | ₫529.51 Billion ≈ $20.12 Million |
₫2.32 Trillion ≈ $88.24 Million |
-1.26pp |
| 2024-12-31 | 24.06% | ₫521.79 Billion ≈ $19.82 Million |
₫2.17 Trillion ≈ $82.41 Million |
+4.52pp |
| 2023-12-31 | 19.54% | ₫415.03 Billion ≈ $15.77 Million |
₫2.12 Trillion ≈ $80.70 Million |
+1.68pp |
| 2022-12-31 | 17.86% | ₫324.33 Billion ≈ $12.32 Million |
₫1.82 Trillion ≈ $69.01 Million |
+1.15pp |
| 2021-12-31 | 16.70% | ₫285.13 Billion ≈ $10.83 Million |
₫1.71 Trillion ≈ $64.86 Million |
+10.19pp |
| 2020-12-31 | 6.51% | ₫107.49 Billion ≈ $4.08 Million |
₫1.65 Trillion ≈ $62.72 Million |
+5.59pp |
| 2019-12-31 | 0.92% | ₫14.50 Billion ≈ $550.91K |
₫1.57 Trillion ≈ $59.71 Million |
-- |
About Traphaco JSC
Traphaco Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam. The company offers medical supplies; antipyretics; medicines for the hair, eyes, central neutral system, respiratory system, and liver; and other products. It is also involved in the production of medicines to treat human diseases,… Read more